Skye Bioscience, Inc. (SKYE) Ownership
SKYE ownership summary
as of October 18, 2026- Institutions
- 46.1% of shares outstanding
- Insiders
- 4.24% of shares outstanding
- Shares outstanding
- 4.4M
- Float
- 3.0M shares available to trade
- Short interest
- 4.67% 148K shares short
- Days to cover
- 1.72 short interest up 26.4% vs prior month
- Institutions 46.12%
- Insiders 4.24%
- Other investors 49.64%
SKYE top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | 5AM Venture Management, LLC | 27.33% | 9.7M | $15.0M | — | June 30, 2026 |
| 2 | Versant Venture Management LLC | 5.67% | 2.0M | $3.1M | — | June 30, 2026 |
| 3 | Baker Bros Advisors LP | 4.45% | 1.6M | $2.4M | — | June 30, 2026 |
| 4 | Vanguard Capital Management, LLC | 2.16% | 764K | $1.2M | −575 (−0.1%) | June 30, 2026 |
| 5 | Sphera Funds Management Ltd. | 1.92% | 679K | $1.1M | — | June 30, 2026 |
| 6 | Junked Platinum Investment Management Ltd | 0.66% | 233K | $361,297 | — | March 31, 2026 |
| 7 | BlackRock Inc | 0.66% | 233K | $360,955 | −53,257 (−18.6%) | June 30, 2026 |
| 8 | Geode Capital Management, LLC | 0.62% | 218K | $337,985 | −59,201 (−21.4%) | June 30, 2026 |
| 9 | Millennium Management LLC | 0.56% | 199K | $307,712 | −59,676 (−23.1%) | June 30, 2026 |
| 10 | Vanguard Fiduciary Trust Co | 0.29% | 104K | $161,555 | — | June 30, 2026 |
| 11 | State Street Corp | 0.21% | 74K | $114,436 | −1,496 (−2.0%) | June 30, 2026 |
| 12 | UBS Group AG | 0.21% | 74K | $114,390 | +28,038 (+61.3%) | June 30, 2026 |
| 13 | Northern Trust Corp | 0.16% | 56K | $87,307 | +36,185 (+179.6%) | June 30, 2026 |
| 14 | Qube Research & Technologies | 0.12% | 43K | $66,777 | +43,082 (0.0%) | June 30, 2026 |
| 15 | SIMPLEX TRADING, LLC | 0.08% | 27K | $41,813 | +26,976 (0.0%) | June 30, 2026 |
| 16 | XTX Topco Ltd | 0.06% | 21K | $32,539 | −19,926 (−48.7%) | June 30, 2026 |
| 17 | Engineers Gate Manager LP | 0.06% | 20K | $31,301 | — | June 30, 2026 |
| 18 | Group One Trading, LLC | 0.01% | 4,589 | $7,113 | −2,616 (−36.3%) | June 30, 2026 |
| 19 | Vanguard Global Advisers, LLC | 0.01% | 4,557 | $7,063 | — | June 30, 2026 |
| 20 | Mercer Global Advisors Inc. | 0.01% | 3,065 | $4,751 | +3,065 (0.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 5 holders added 137K shares and 7 cut 197K.
SKYE top mutual fund and ETF holders
10 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | RHB Equity Trust | 2.27% | 100K | $155,465 | +100,300 (0.0%) | June 30, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 1.59% | 70K | $108,855 | — | August 31, 2026 |
| 3 | Fidelity Extended Market Index | 0.32% | 14K | $21,618 | −75 (−0.5%) | August 31, 2026 |
| 4 | Abante Quant Value FI | 0.21% | 9,087 | $14,085 | — | August 31, 2026 |
| 5 | Fidelity Total Market Index | 0.09% | 3,829 | $5,935 | −1 (−0.0%) | August 31, 2026 |
| 6 | Fidelity Series Total Market Index | 0.07% | 3,047 | $4,723 | — | August 31, 2026 |
| 7 | Vanguard Balanced Index Inv | 0.05% | 2,134 | $3,308 | — | August 31, 2026 |
| 8 | Fidelity Nasdaq Composite Index | 0.03% | 1,451 | $2,249 | — | August 31, 2026 |
| 9 | Vanguard U.S. Eq Idx £ Acc | 0.01% | 569 | $882 | −1 (−0.2%) | August 31, 2026 |
| 10 | Global FML Fund R | 0.00% | 2 | $3 | −1 (−33.3%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
SKYE insider transactions
latest 4| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2025-08-22 | 5Am Partners Vii, Llc | Sell | $3.42 | 170,449 | $582,936 |
| 2025-08-22 | Andrew J Schwab | Sell | $3.42 | 170,449 | $582,936 |
| 2025-08-21 | 5Am Partners Vii, Llc | Sell | $3.57 | 60,956 | $217,613 |
| 2025-08-21 | Andrew J Schwab | Sell | $3.57 | 60,956 | $217,613 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
SKYE shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns SKYE
Institutional investors own 46.1% of Skye Bioscience's shares and insiders 4.24%. The largest holder is 5AM Venture Management, LLC with 27.33% of the shares (9.7M), as of June 30, 2026. Among the top 20 institutions, 5 added shares and 7 reduced their stake in the latest filings. Short interest is 4.67% of the float, or 1.72 days of average trading volume. The share count rose 93,443.4% since 2014.
Related: SKYE analyst forecast, SKYE key metrics. See the SKYE stock overview for the latest quote and news.
SKYE ownership FAQ
Who owns the most Skye Bioscience stock?
The largest shareholders of Skye Bioscience are 5AM Venture Management, LLC (27.33%), Versant Venture Management LLC (5.67%), Baker Bros Advisors LP (4.45%), Vanguard Capital Management, LLC (2.16%), Sphera Funds Management Ltd. (1.92%).
What percentage of Skye Bioscience is owned by institutions?
Institutions hold 46.1% of Skye Bioscience's shares outstanding; insiders hold 4.24%.
Which funds own Skye Bioscience?
The largest fund holders of Skye Bioscience are RHB Equity Trust (2.27%), Vanguard MStar Total Stk Mkt Idx Invest (1.59%), Fidelity Extended Market Index (0.32%), Abante Quant Value FI (0.21%), Fidelity Total Market Index (0.09%).
What is Skye Bioscience's short interest?
148K shares of Skye Bioscience were sold short, 4.67% of the float; at the average daily volume it would take 1.72 days to cover.
Are insiders buying or selling Skye Bioscience?
Of the latest 4 reported insider transactions in Skye Bioscience (since August 21, 2025), 0 were purchases and 4 were sales.
How many shares of Skye Bioscience are outstanding?
Skye Bioscience has 4.4M shares outstanding, of which 3.0M are in the public float.